SOW
RGC icon

State of Wyoming’s Regencell Bioscience RGC Stock Holding History

State of Wyoming’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
+4,070
New +$97.7K ﹤0.01% 1773

Other funds holding RGC

FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

State of Wyoming's RGC Position: Q2 2026 in Review

State of Wyoming opened a new position in Regencell Bioscience (RGC) in Q2 2026: 4,070 shares worth $24.8K. The stake represents ﹤0.01% of the portfolio and ranks #1773 among its holdings.

8 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • State of Wyoming held 4,070 shares of Regencell Bioscience worth $24.8K as of Q2 2026.
  • Regencell Bioscience was a new State of Wyoming position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1773 holding.
  • 8 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.